[Federal Register Volume 63, Number 59 (Friday, March 27, 1998)]
[Notices]
[Page 14963]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-8084]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 23, 1998, Ganes 
Chemicals, Inc., Industrial Park Road, Pennsville, New Jersey 08070, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Methylphenidate (1724).....................  II                         
Amobarbital (2125).........................  II                         
Pentobarbital (2270).......................  II                         
Secobarbital (2315)........................  II                         
Glutethimide (2550)........................  II                         
Methandone (9250)..........................  II                         
Methadone-intermediate (9254)..............  II                         
Dextropropoxyphene, bulk (non-dosage forms)  II                         
 (9273).                                                                
------------------------------------------------------------------------

    The firm plans to manufacture the controlled substances for 
distribution as bulk products to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above proposed application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than May 26, 1998.

    Dated: March 16, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-8084 Filed 3-36-98; 8:45 am]
BILLING CODE 4410-09-M